Connecting Globally….Treating Locally
“Improving communication between patient and doctor by giving you the same language and understanding of your disease”
Malecare is America’s leading men’s cancer survivor support and advocacy national nonprofit organization. Malecare, Inc. is a 501(c)(3) nonprofit organization, run by oncologists, psychologists, and social workers.
Malecare sets the standard for best practice of patient peer to peer support. We push the limits of technology to create personalized cancer information delivery. We design great projects for communities ignored by commercial and mainstream organizations. Our goal is to help men and their loved ones live longer and happier lives.
We have a deep understanding of our patient population. We develop and implement cutting edge methods to service our cancer survivor population.
We’ve pioneered several men’s health programs for underserved populations, like African-American, LGBT and Native American cancer survivors. All of our services are provided without cost to the patient and their family.
Malecare is the world’s first cancer survivor organization to present programs focused on gay and bisexual men’s cancer survivorship, starting in 1998. In 2005, Malecare developed the world’s first cancer survivor program focused on serving all Lesbian, Gay, Bisexual and Transgender people, the National LGBT Cancer Project, which can be seen at https://lgbtcancer.org and the LGBT cancer patient registery, Out With Cancer. Malecare currently facilitates the worlds largest gay men’s prostate cancer support network and is internationally recognized for our LGBT cancer patient advocacy and research.
In 2002, Malecare began a program to reduce the disparity of prostate cancer-killing African-American men at twice the rate as Caucasian men, with our African-American Prostate Cancer Research Directory. That program is now known as Twice As Many and can be seen at https://twiceasmany.org . Malecare’s Black Dad Connection program, focusing on improving health and parenting skills for African American fathers, began in 2005. Our booklet, Prostate Cancer While Black, is a seminal presentation of the psychosocial and racist barriers faced by Black men with prostate cancer in America.
In 2006, Malecare began the world’s first psychosocial support program to focus on men with advanced stage prostate cancer. Malecare currently facilitates the world’s largest advanced stage prostate cancer support group network.
In 2011, Malecare began the Global Prostate Cancer Alliance, an international collaboration of national prostate cancer organizations throughout the world, as a cross border health care policy and awareness cross border collaboration. The Global Prostate Cancer Alliance international prostate cancer alliance can be seen at https://prostatecanceralliance.org .
In 2013, Malecare began the world’s first cancer research crowdfunding platform, Start A Cure (currently inactive). Current research funded directly by Malecare can be seen at https://malecare.org/prostate-cancer-research-patents/ .
In 2013, Malecare developed a new model for patient advocacy, which we call, Patient Action Leaders. Examples of recent success for that model can be seen at https://malecare.org/advocacy/
In 2014, Malecare became the first American prostate cancer nonprofit organization to earn a patent for a medical device. That patent can be seen here: Device and method for measuring radiation exposure
In 2015, Malecare launched the patent pending Quality of Life serial data collection mobile app, Cancergraph You can read more about Cancergraph here: https://cancergraph.com
In 2017, Malecare, in collaboration with our academic partner the University of Minnesota, became the first prostate cancer nonprofit to co-receive NIH/NCI funding for a clinical trial. That trial can be seen here: https://clinicaltrials.gov/ct2/show/NCT03343093?term=malecare&rank=1
In 2019, Malecare produces the worlds first Prostate Cancer Patient Conference to feature an all female faculty of 14 clinicians.
In 2020, Malecare produces the world’s largest Prostate Cancer Patient Conference, with a faculty of 43 clinicians making 64 presentations.